Literature DB >> 15981920

HPMA copolymer-bound doxorubicin induces apoptosis in human ovarian carcinoma cells by a Fas-independent pathway.

Alexander Malugin1, Pavla Kopecková, Jindrich Kopecek.   

Abstract

The mechanism of cell death in A2780 human ovarian carcinoma cells induced by free doxorubicin (DOX) and N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer-bound DOX [P-(GFLG)-DOX] was investigated. In particular, the involvement of the Fas receptor system in drug-induced apoptosis was evaluated. P-(GFLG)-DOX was shown to effect apoptosis-induced tumor cell death as manifested by positive Annexin V-FITC staining, cleavage of procaspase 3 and its physiological substrate, poly(ADP-ribose) polymerase (PARP), and cleavage of procaspase 8. Using the fluorochrome-labeled caspase inhibitor assay, it was found that both free DOX and P-(GFLG)-DOX activated caspases 3 and 9, but both forms of DOX did not have an effect on the activity of caspase 8, when compared to untreated cells. It was shown that free DOX and P-(GFLG)-DOX upregulated Fas receptor expression at the cell membrane in a time-dependent manner. Triggering the drug-induced Fas receptor with an exogeneous soluble Fas ligand (sFasL) resulted in an increase in the extent of apoptotic cell death, indicating that the Fas signaling pathway remained functionally active. Also, antagonistic anti-Fas ZB4 antibody blocked the increase in the level of apoptosis following the application of sFasL, but did not interfere with drug-induced apoptosis. The study of the functional activity of the Fas receptor and of the activation of the most proximal effector of the caspase cascade, caspase 8, indicated that the Fas receptor pathway was not decisive in the induction of cell death by free DOX and P-(GFLG)-DOX in A2780 cells. This study suggests further investigation of the involvement of the mitochondrial pathway in A2780 cell apoptotic death, induced by free and HPMA copolymer-bound DOX.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15981920     DOI: 10.1021/mp049967q

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  5 in total

1.  HPMA copolymer-bound doxorubicin induces apoptosis in ovarian carcinoma cells by the disruption of mitochondrial function.

Authors:  Alexander Malugin; Pavla Kopecková; Jindrich Kopecek
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

2.  Targeted sialic acid-doxorubicin prodrugs for intracellular delivery and cancer treatment.

Authors:  Sreeja Jayant; Jayant J Khandare; Yang Wang; Ajay P Singh; Nicholi Vorsa; Tamara Minko
Journal:  Pharm Res       Date:  2007-08-01       Impact factor: 4.200

3.  HPMA copolymers: origins, early developments, present, and future.

Authors:  Jindrich Kopecek; Pavla Kopecková
Journal:  Adv Drug Deliv Rev       Date:  2009-11-14       Impact factor: 15.470

4.  Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells.

Authors:  A Malugin; P Kopecková; J Kopecek
Journal:  J Control Release       Date:  2007-08-23       Impact factor: 9.776

5.  Kaurene diterpene induces apoptosis in U87 human malignant glioblastoma cells by suppression of anti-apoptotic signals and activation of cysteine proteases.

Authors:  F S Lizarte Neto; D P C Tirapelli; S R Ambrosio; C R Tirapelli; F M Oliveira; P C Novais; F M Peria; H F Oliveira; C G Carlotti Junior; L F Tirapelli
Journal:  Braz J Med Biol Res       Date:  2013-01-11       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.